Navigation Links
Cephalon Launches Takeover Offer for Australian Biotechnology Company, Arana Therapeutics
Date:2/26/2009

nt portfolios by taking cash for their shares at a time when cash provides certainty and stability," said Kevin Buchi, chief financial officer at Cephalon. "We are better equipped to take Arana's lead compound, ART621, through clinical development and, pending the success of clinical trials, to international markets."

To support its bid, Cephalon has acquired a shareholding in Arana, representing an ownership position of approximately 19.9 percent of the total issued share capital of Arana. The purchase price of the shares was A$1.40 per share. Cephalon has acquired this stake from Arana's two largest shareholders, Start-up Australia Ventures Pty Ltd and Rockwell Securities Limited.

Cephalon's offer will be subject to certain basic conditions (outlined in Appendix A), including a 50.1 percent minimum acceptance condition.

Cephalon is well advanced in the preparation of its Bidder's Statement, and expects the offer will be open for acceptance by mid-March.

Arana is a biopharmaceutical company focused on developing next generation antibody based drugs that will improve the lives of patients with inflammatory diseases and cancer. The company's lead compound, ART621, is a new generation tumor necrosis factor (TNF ) alpha blocker in development for patients with inflammatory diseases. Arana has a strong patent portfolio related to anti-TNF alpha antibodies and receives royalties from Abbott Laboratories and Johnson & Johnson, the makers of HUMIRA(R) and REMICADE(R), respectively. Cephalon expects these royalties largely to offset costs of development in the near term. Therefore, Cephalon is making no change to its 2009 adjusted net income guidance.

"Arana would bolster our burgeoning inflammatory disease pipeline as well as our oncology pipeline," said Frank Baldino, Jr., Ph.D., chairman and CEO of Cephalon. "Arana has an established protein engineering technology platform
'/>"/>

SOURCE Cephalon, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine news :

1. Major Pharma Clinical Case Studies From Amgen, AstraZeneca, GSK, Intermune, Cephalon Inc, Sunesis Pharmaceuticals and Dartmouth Medical School During Fall Clinical Focused Programs
2. Cephalon Submits New Drug Application for TREANDA for the Treatment of Chronic Lymphocytic Leukemia
3. Cephalon Appoints Valli F. Baldassano as Executive Vice President and Chief Compliance Officer
4. Cephalon to Present at the 26th Annual JP Morgan Healthcare Conference
5. inVentiv Selling Solutions Selected to Provide Sales Team for Cephalon Inc.
6. Cephalon Appoints Gerald J. Pappert as General Counsel
7. Cephalon Reports Strong First Quarter Earnings
8. Cephalon Conference Call Invitation
9. Cephalon Announces FDA Advisory Committee Recommendation Against Approval of an Expanded Label for FENTORA
10. Biopharmaceutical Company, Cephalon, To Pay $425 Million & Enter Plea to Resolve Allegations of Off-Label Marketing
11. Ohio Sales Reps Information Launched Massive Government Investigation of Cephalon
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2015)... TX (PRWEB) March 27, 2015 The ... is an essential source of information on and analysis ... US. The population of the US in 2013 amounted ... Growth Rate (CAGR) of 0.8% from 2008. The country’s ... of chronic diseases will help to boost the growth ...
(Date:3/27/2015)... Naples, FL and London, UK (PRWEB) March 27, 2015 ... solution, announced today that it has appointed Sean Fitzgerald, ... the role of Chief Operating Officer and Interim Chief ... Vice President of leading education technology innovator, EverFi, backed ... Eric Schmidt, and Twitter founder Evan Williams. Prior to ...
(Date:3/27/2015)... GrassrootsHealth, an international nonprofit public health ... NOW! vitamin D demonstration project April 7 in the ... (MUSC), and will soon follow with a second phase ... to a minimum of 500 pregnant women at 17 ... service areas. The project will include patient and health ...
(Date:3/27/2015)... 2015 When struck with the aftermath ... know where to begin. The latest eBook released ... attorney, offers accident victims a clear and concise process ... ensure their personal injury claim is seen through to ... first actions that should be taken immediately following the ...
(Date:3/27/2015)... Trail mix is the perfect, healthy snack ... hikes and during the game! It’s portable, lightweight and provides ... to introduce a new line of specialty trail mixes that ... flavorful selections packed with nutritious, 100% all natural ingredients. , ... that add protein and fiber to your diet and boost ...
Breaking Medicine News(10 mins):Health News:US Pharmaceutical Market worth $548.4 billion by 2020 Says a New Report Available at RnRMarketResearch.com 2Health News:US Pharmaceutical Market worth $548.4 billion by 2020 Says a New Report Available at RnRMarketResearch.com 3Health News:US Pharmaceutical Market worth $548.4 billion by 2020 Says a New Report Available at RnRMarketResearch.com 4Health News:GenSight Appoints Former Technology Executive as Chief Operating Officer 2Health News:GrassrootsHealth Moves Vitamin D into Practice with Pregnant Women 2Health News:GrassrootsHealth Moves Vitamin D into Practice with Pregnant Women 3Health News:GrassrootsHealth Moves Vitamin D into Practice with Pregnant Women 4Health News:Dax Jones Updated eBook on Trucking Accidents Offers Helpful Information to Crash Victims 2Health News:Aurora Product, Inc. Introduces New Line of Specialty Trail Mixes 2
... Older adults who don,t get enough vitamin D ... at increased risk of developing mobility limitations and disability, according ... "This is one of the first studies to look at ... mobility limitations or disability in older adults," said lead author ...
... been approved since March 2011 in men with metastatic ... with hormone blockers and have already been pre-treated with ... pursuant to the "Act on the Reform of the ... Quality and Efficiency in Health Care (IQWiG) examined whether ...
... of Physicians (ACP), the second-largest physician group in the United ... aims to prevent one million heart attacks and strokes in ... Empowering Americans to make healthy choices such as preventing ... can reduce the number of people who need medical treatment ...
... Vitamin D deficiency is not healthy. However, new research from ... level of the essential vitamin is not good either. The ... results have just been published in the reputed scientific ... is instrumental in helping calcium reach our bones, thus lessening ...
... aspirin and other similar painkillers may help protect against ... a peer-reviewed journal of the American Cancer Society, the ... to the benefits of these commonly used medications. ... NSAIDs, which include aspirin, ibuprofen, and naproxen, as well ...
... Aggressive efforts to lower blood pressure in people with ... a new study The research shows that there ... with diabetes in the U.S. Department of Veterans Affairs, with ... controlled and 94 percent getting appropriate BP treatment. ...
Cached Medicine News:Health News:Older adults may need more vitamin D to prevent mobility difficulties 2Health News:Cabazitaxel can offer an advantage in certain patients 2Health News:Cabazitaxel can offer an advantage in certain patients 3Health News:ACP joins Million Hearts to help save lives from preventable heart attacks and strokes 2Health News:Too much vitamin D can be as unhealthy as too little 2Health News:Commonly used painkillers may protect against skin cancer 2Health News:1 size doesn't fit all when treating blood pressure in people with diabetes, VA/U-M study suggests 2Health News:1 size doesn't fit all when treating blood pressure in people with diabetes, VA/U-M study suggests 3
(Date:3/26/2015)... 26, 2015 /PRNewswire/ - Pivotal Therapeutics Inc. (OTCQX:PVTTF; CSE:PVO), ("Pivotal" ... focus on Omega-3 therapies for cardiovascular disease and overall ... 763,752 common shares of the Corporation (the "Common Shares"). ... period of December 5 th , 2014 to March ... that is due on or before April 1, 2015. ...
(Date:3/26/2015)... -- "Whether it,s our family, our friends, all of ... a single sentence, Dr. Anthony Coyle , senior ... Centers for Therapeutic Innovation (CTI), sums up what ... biopharmaceutical companies. CTI,s unique model allows ... and the National Institutes of Health (NIH) to bridge ...
(Date:3/26/2015)... 2015 Cardiologists at Beaumont Hospital, ... commercial implant of a device recently approved by the ... fibrillation. The Watchman Left Atrial Appendage Closure implant is ... to reduce the risk of stroke. Atrial ... more than 5 million Americans. Twenty percent of all ...
Breaking Medicine Technology:Pivotal Therapeutics announces payment of interest on outstanding convertible notes 2Collaboration for Cures: Teaming Up to Advance Science and Save Lives 2Beaumont Hospital, Royal Oak among first to offer alternative to blood-thinning medications for atrial fibrillation 2Beaumont Hospital, Royal Oak among first to offer alternative to blood-thinning medications for atrial fibrillation 3
... SILVER SPRING, Md., Dec. 20, 2010 Each year, ... drugs that treat a wide variety of conditions and ... recent significant FDA approvals for generic medications, go to ... notices of new FDA Consumer Updates at: ...
... Inc. today announced the development of software that uses ... assist ophthalmologists and optometrists in diagnosing retinal and optic ... is an imaging technique used to provide ophthalmologists and ... (RNFL) which can help them diagnose diseases like glaucoma. ...
Cached Medicine Technology:New Software for Improving the Analysis of OCT Images 2
Accu-Stat Home Drug Test for Marijuana (THC), Cocaine (COC), Amphetamine (AMP), Methamphetamine (mAMP), Opiates (OPI), and Phencyclidine (PCP)....
... SEDIPLAST® is a completely closed system ... laboratory personnel from the risk associated ... uniquely designed erythrocyte sedimentation rate test ... convenience as well as reliable and ...
... Unlike other ESR products, SEDIPLAST® is ... design features to protect laboratory personnel ... handling. SEDIPLAST® is a uniquely designed ... provides greater safety and convenience as ...
... The use of guaiac as ... of blood is based on ... present in guaiac to quinones, ... a blue color. If blood ...
Medicine Products: